(FFN) Ciencias Farmacéuticas
Departamento académico
![Foto de (FFN) Ciencias Farmacéuticas](/img/uploaded/7BBF98BABED44170609D1F8CE8983350.jpg)
![Foto de Novartis (Sweden)](/img/noimage_org.png)
Novartis (Sweden)
Täby, SueciaPublicaciones en colaboración con investigadores/as de Novartis (Sweden) (5)
2015
-
Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development
CPT: Pharmacometrics and Systems Pharmacology, Vol. 4, Núm. 6, pp. 316-319
2014
-
A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis
CPT: Pharmacometrics and Systems Pharmacology, Vol. 3, Núm. 5
2010
-
Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: A conceptual framework
Basic and Clinical Pharmacology and Toxicology
-
Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics
European Journal of Cancer, Vol. 46, Núm. 1, pp. 21-32
2004
-
Modelling and simulation in the development and use of anti-cancer agents: An underused tool?
Journal of Pharmacokinetics and Pharmacodynamics